# Preeclampsia: A Marker for Future Cardiovascular Risk in Women

> **NCT01519297** · NA · SUSPENDED · sponsor: **Brigham and Women's Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Preeclampsia
- Pregnancy Induced Hypertension

## Interventions

- **DRUG:** Irbesartan

## Key facts

- **NCT ID:** NCT01519297
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2012-05
- **Primary completion:** 2017-07
- **Final completion:** 2019-07
- **Target enrollment:** 150 (ESTIMATED)
- **Why stopped:** Pending funding
- **Last updated:** 2019-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01519297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01519297, "Preeclampsia: A Marker for Future Cardiovascular Risk in Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01519297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*